[1] ARORA A, PRAUSNITZ M R, MITRAGOTRI S. Micro-scale devices for transdermal drug delivery[J]. Int J Pharm, 2008,364(2):227-236.
[2] TUAN-MAHMOOD T M, MCCRUDDEN M T, TORRISI B M, et al. Microneedles for intradermal and transdermal drug delivery[J]. Eur J Pharm Sci, 2013,50(5):623-637.
[3] BAL S M, DING Z, VAN RIET E, et al. Advances in transcutaneous vaccine delivery: do all ways lead to Rome?[J]. J Controlled Release, 2010,148(3):266-282.
[4] HARDING C R. The stratum corneum: structure and function in health and disease[J]. Dermatologic Therapy, 2004,17(suppl 1):6-15.
[5] MAIBACH H. Dermatological formulations: percutaneous absorption[J]. J Pharm Sci, 1984,73(4):573.
[6] TAGAMI H, KOBAYASHI H, ZHEN X S, et al. Environmental effects on the functions of the stratum corneum[J]. J Invest Dermatol Symposium Proc, 2001,6(1):87-94.
[7] MOORE T L, LUNT M, MCMANUS B, et al. Seventeen-point dermal ultrasound scoring system--a reliable measure of skin thickness in patients with systemic sclerosis[J]. Rheumatology, 2003,42(12):1559-1563.
[8] ZHANG X J, HE C D, LU H G. Dermatovenereology(皮肤性病学)[M]. Vol 7. Beijing: People's Medical Publishing House,2008:5.
[9] CHEN J, CHEN Z P, QU M M. Application of microneedles in transdermal drug delivery[J]. Int J Pharm Res(国际药学研究杂志), 2011,38(2):142-147.
[10] WIECHERS J W. The barrier function of the skin in relation to percutaneous absorption of drugs[J]. Pharm Weekblad Sci Ed, 1989,11(6):185-198.
[11] EL-DOMYATI M, BARAKAT M, AWAD S, et al. Multiple microneedling sessions for minimally invasive facial rejuvenation: an objective assessment[J]. Int J Dermatol, 2015,54(12):1361-1369.
[12] LI W Z, ZHANG H, HAN W X, et al. Study on the safety of solid microneedles for transdermal drug delivery[J]. Chin Pharm J(中国药学杂志), 2011,46(23):1818-1822.
[13] BOS J D, MEINARDI M M. The 500 dalton rule for the skin penetration of chemical compounds and drugs[J]. Exper Dermatol, 2000,9(3):165-169.
[14] HARVEY A J, KAESTNER S A, SUTTER D E, et al. Microneedle-based intradermal delivery enables rapid lymphatic uptake and distribution of protein drugs[J]. Pharm Res, 2011,28(1):107-116.
[15] LIU S, JIN M N, QUAN Y S, et al. The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin[J]. J Controlled Release, 2012,161(3):933-941.
[16] CHEN M C, LING M H, KUSUMA S J. Poly-gamma-glutamic acid microneedles with a supporting structure design as a potential tool for transdermal delivery of insulin[J]. Acta Biomater, 2015,24(15):106-116.
[17] KIM M C, LEE J W, CHOI H J, et al. Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection[J]. J Controlled Release, 2015,210(1):208-216.
[18] HIROBE S, AZUKIZAWA H, HANAFUSA T, et al. Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch[J]. Biomaterials, 2015,57(22):50-58.
[19] DAUGIMONT L, BARON N, VANDERMEULEN G, et al. Hollow microneedle arrays for intradermal drug delivery and DNA electroporation[J]. J Membrane Biol, 2010,236(1):117-125.
[20] DENG Y, CHEN J, ZHAO Y, et al. Transdermal delivery of siRNA through microneedle array[J]. Scientific Reports, 2016,6(1):21422.
[21] YAN G, WARNER K S, ZHANG J, et al. Evaluation needle length and density of microneedle arrays in the pretreatment of skin for transdermal drug delivery[J]. Int J Pharm, 2010,391(1-2):7-12.
[22] MILEWSKI M, PAUDEL K S, BROGDEN N K, et al. Microneedle-assisted percutaneous delivery of naltrexone hydrochloride in yucatan minipig: in vitro-in vivo correlation[J]. Molecular Pharm, 2013,10(10):3745-3757.
[23] VERBAAN F J, BAL S M, VAN DEN BERG D J, et al. Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin[J]. J Controlled Release, 2007,117(2):238-245.
[24] HAQ M I, SMITH E, JOHN D N, et al. Clinical administration of microneedles: skin puncture, pain and sensation[J]. Biomed Microdevices, 2009,11(1):35-47.
[25] KALLURI H, KOLLI C S, BANGA A K. Characterization of microchannels created by metal microneedles: formation and closure[J]. The AAPS J, 2011,13(3):473-481.
[26] NAGUIB Y W, KUMAR A, CUI Z. The effect of microneedles on the skin permeability and antitumor activity of topical 5-fluorouracil[J]. Acta Pharm Sin B(药学学报B), 2014,4(1):94-99.
[27] WERMELING D P, BANKS S L, HUDSON D A, et al. Microneedles permit transdermal delivery of a skin-impermeant medication to humans[J]. Proc Nati Acad Sci, 2008,105(6):2058-2063.
[28] BANKS S L, PAUDEL K S, BROGDEN N K, et al. Diclofenac enables prolonged delivery of naltrexone through microneedle-treated skin[J]. Pharm Res, 2011,28(5):1211-1219.
[29] KUSAMORI K, KATSUMI H, SAKAI R, et al. Development of a drug-coated microneedle array and its application for transdermal delivery of interferon alpha[J]. Biofabrication, 2016,8(1):015006.
[30] GUPTA J, PARK S S, BONDY B, et al. Infusion pressure and pain during microneedle injection into skin of human subjects[J]. Biomaterials, 2011,32(28):6823-6831.
[31] GRISS P, STEMME G. Side-opened out-of-plane microneedles for microfluidic transdermal liquid transfer[J]. J Microelectromechanical Sys, 2003,12(3):296-301.
[32] WANG P M, CORNWELL M, HILL J, et al. Precise microinjection into skin using hollow microneedles[J]. J Invest Dermatol, 2006,126(5):1080-1087.
[33] KALLURI H, BANGA A K. Formation and closure of microchannels in skin following microporation[J]. Pharm Res, 2011,28(1):82-94.
[34] KATSUMI H, LIU S, TANAKA Y, et al. Development of a novel self-dissolving microneedle array of alendronate, a nitrogen-containing bisphosphonate: evaluation of transdermal absorption, safety, and pharmacological effects after application in rats[J]. J Pharm Sci, 2012,101(9):3230-3238.
[35] DANGOL M, YANG H, LI C G, et al. Innovative polymeric system (IPS) for solvent-free lipophilic drug transdermal delivery via dissolving microneedles[J]. J Controlled Release, 2016,223(1):118-125.